Business
PIHN Plans for Rapid Expansion With New Sales Offices in Florida, Canada and Mexico
PIHN Plans for Rapid Expansion With New Sales Offices in Florida, Canada and Mexico.
About this update from Polaris International Holdings Inc.
[{"type":"text","content":"\n \n \n PIHN Plans for Rapid Expansion With New Sales Offices in Florida, Canada and Mexico\n \n \nPIHN Plans for Rapid Expansion With New Sales Offices in Florida, Canada and Mexico\n \n PLANO, TX--(Marketwired - Apr 9, 2014) - Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is excited to announce its medical division, ProCannas, is opening three new sales offices in Tampa, FL; Vancouver, British Columbia, Canada; and Mexico City, Mexico in the Summer of 2014. The Company is also exploring the possibility of distribution channels in select areas throughout India and Asia.\n The Company has received multiple requests from Physicians in Tampa and other parts of Florida to begin trials with our transdermal cannabinoid patch. The Company's sales offices will assist the Physicians with implementation of the trials using the Company's proprietary tracking software. \n \"The Company believes that establishing these sales locations will provide more efficient customer service to our participating physicians and be more economically favorable to the Company's bottom line. Physicians feel more comfortable having a sales and service person in the area rather than a customer service representative over the phone,\" states Medical Director Dr. Vasthi Alvarez Avila.\n ABOUT THE COMPANY\n ProCannas' core business focuses on the manufacture and distribution of new, pharmaceutical grade cannabinoid based products for medicinal use. Due to the concentrated strength and unique mix of ingredients integrated within our products, they are intended to be available to patients only through licensed participating physicians. Due to recent changes in the law regarding the medical use of marijuana, coupled with studies and a strong body of evidence highlighting that THC is not the significant component for medicinal use, doors are opening for innovation. Laws are expected to become even more favorable for companies like ProCannas. The Company intends to target a broad range of specialties with this novel product, including but not limited to sports medicine, pain management, neurology, and osteopathic medicine.\n Safe Harbor Statement:\n This news release includes forward-looking statements pertaining to future anticipated projected plans, performance and developments, intended to qualify for the sa...